17752

    530549

    SHILPAMED

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SHILPA MEDICARE LTD Share Price Today

    SHILPA MEDICARE LTD is currently trading at ₹737.65, down by ₹1.14 from the previous close. The stock touched an intraday high of ₹740.00 and a low of ₹740.00 during the latest trading session. Over the past one year, SHILPA MEDICARE LTD has delivered a return of 67.47%, while the stock has gained 20.95% in the last one month.

    SHILPA MEDICARE LTD performance

    Today’s low Today’s high
    ₹ 740.00 ₹ 740.00
    ₹ 738.80
    52 week low 52 week high
    ₹ 259.50 ₹ 786.15
    ₹ 738.80
    Open Price ₹ 740.00
    Prev. Close ₹ 738.80
    Volume (Shares) 20729663.00
    Total traded value ₹ 153150.75
    Upper Circuit ₹ 886.55
    Lower Circuit ₹ 591.05
    info

    Investment Returns

    Over 1 Month 20.95% Over 3 Months 70.06% Over 6 Months 128.47% Over 1 Year 67.47%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SHILPA MEDICARE LTD fundamentals


    • Market cap (Cr) 14,449.60
    • P/E Ratio (TTM) 106.08
    • Beta 0.88
    • Book Value / share 138.73
    • Return on equity 3.92%
    • EPS (TTM) 5.91
    • Dividend yield 0.08%
    • Net profit/quarter (Cr) 64.92
    info icon alternate text
    • Market cap (Cr) 14,474.00
    • P/E Ratio (TTM) 106.08
    • Beta 0.81
    • Book Value / share 138.73
    • Return on equity 3.92%
    • EPS (TTM) 5.91
    • Dividend yield 0.08%
    • Net profit/quarter (Cr) 64.92
    info icon alternate text

    SHILPA MEDICARE LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 189.04
    Operating Expense 151.05
    Net Profit 64.92
    Net Profit Margin (%) 34.34
    Earnings Per Share (EPS) 3.32
    EBITDA 69.08
    Effective Tax Rate (%) -27.14
    Particulars MAR 2026 (Values in Cr)
    Revenue 201.11
    Operating Expense 158.35
    Net Profit 70.96
    Net Profit Margin (%) 35.28
    Earnings Per Share (EPS) 3.63
    EBITDA 95.05
    Effective Tax Rate (%) 9.04
    Particulars DEC 2025 (Values in Cr)
    Revenue 165.70
    Operating Expense 151.00
    Net Profit 15.93
    Net Profit Margin (%) 9.61
    Earnings Per Share (EPS) 0.84
    EBITDA 40.09
    Effective Tax Rate (%) 32.99
    Particulars SEP 2025 (Values in Cr)
    Revenue 134.93
    Operating Expense 111.38
    Net Profit 30.83
    Net Profit Margin (%) 22.84
    Earnings Per Share (EPS) 3.16
    EBITDA 54.51
    Effective Tax Rate (%) 20.81
    Particulars JUN 2025 (Values in Cr)
    Revenue 92.43
    Operating Expense 90.26
    Net Profit 20.70
    Net Profit Margin (%) 22.39
    Earnings Per Share (EPS) 2.12
    EBITDA 29.61
    Effective Tax Rate (%) -39.95
    Particulars MAR 2026 (Values in Cr)
    Revenue 597.03
    Operating Expense 506.46
    Net Profit 132.97
    Net Profit Margin (%) 22.27
    Earnings Per Share (EPS) 6.80
    EBITDA 213.27
    Effective Tax Rate (%) 10.23
    Particulars MAR 2025 (Values in Cr)
    Revenue 477.41
    Operating Expense 396.01
    Net Profit 67.89
    Net Profit Margin (%) 14.22
    Earnings Per Share (EPS) 6.97
    EBITDA 160.06
    Effective Tax Rate (%) 35.54
    Particulars MAR 2024 (Values in Cr)
    Revenue 309.79
    Operating Expense 350.37
    Net Profit 26.94
    Net Profit Margin (%) 8.69
    Earnings Per Share (EPS) 3.10
    EBITDA 104.96
    Effective Tax Rate (%) 29.27
    Particulars MAR 2023 (Values in Cr)
    Revenue 247.70
    Operating Expense 359.08
    Net Profit 57.19
    Net Profit Margin (%) 23.08
    Earnings Per Share (EPS) 6.59
    EBITDA 9.09
    Effective Tax Rate (%) 15.08
    Particulars MAR 2022 (Values in Cr)
    Revenue 356.95
    Operating Expense 379.13
    Net Profit 140.99
    Net Profit Margin (%) 39.49
    Earnings Per Share (EPS) 16.87
    EBITDA 71.36
    Effective Tax Rate (%) 26.66
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 242.58
    ROE % 4.21
    ROCE % 7.69
    Total Debt to Total Equity 0.36
    EBITDA Margin 26.07
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 208.37
    ROE % 1.72
    ROCE % 5.16
    Total Debt to Total Equity 0.48
    EBITDA Margin 21.48
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 205.44
    ROE % -1.72
    ROCE % 0.79
    Total Debt to Total Equity 0.41
    EBITDA Margin 11.03
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 209.93
    ROE % 3.67
    ROCE % 5.84
    Total Debt to Total Equity 0.46
    EBITDA Margin 19.49
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 181.37
    ROE % 7.20
    ROCE % 7.58
    Total Debt to Total Equity 0.44
    EBITDA Margin 23.38
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 276.16
    ROE % 3.92
    ROCE % 6.20
    Total Debt to Total Equity 0.05
    EBITDA Margin 43.43
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 246.85
    ROE % 1.59
    ROCE % 2.77
    Total Debt to Total Equity 0.10
    EBITDA Margin 37.06
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 243.96
    ROE % 3.49
    ROCE % -0.84
    Total Debt to Total Equity 0.12
    EBITDA Margin 10.08
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 237.97
    ROE % 7.17
    ROCE % 1.10
    Total Debt to Total Equity 0.23
    EBITDA Margin 17.57
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 200.89
    ROE % 8.93
    ROCE % 2.09
    Total Debt to Total Equity 0.33
    EBITDA Margin 25.61
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 28.52
    Total Assets 3310.70
    Total Liabilities 3310.70
    Total Equity 2363.70
    Share Outstanding 9
    Price to Book Ratio 2.40
    Return on Assets (%) 2.36
    Return on Capital (%) 2.65
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 30.43
    Total Assets 3093.20
    Total Liabilities 3093.20
    Total Equity 1799.95
    Share Outstanding 8
    Price to Book Ratio 1.87
    Return on Assets (%) 1.03
    Return on Capital (%) 1.17
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 21.56
    Total Assets 2903.92
    Total Liabilities 2903.92
    Total Equity 1774.35
    Share Outstanding 8
    Price to Book Ratio 0.94
    Return on Assets (%) -1.12
    Return on Capital (%) -1.27
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 34.11
    Total Assets 2875.49
    Total Liabilities 2875.49
    Total Equity 1811.14
    Share Outstanding 8
    Price to Book Ratio 1.67
    Return on Assets (%) 2.10
    Return on Capital (%) 2.43
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 123.10
    Total Assets 2632.36
    Total Liabilities 2632.36
    Total Equity 1467.49
    Share Outstanding 8
    Price to Book Ratio 1.66
    Return on Assets (%) 5.61
    Return on Capital (%) 6.39
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.42
    Total Assets 3006.66
    Total Liabilities 3006.66
    Total Equity 2700.59
    Share Outstanding 9
    Price to Book Ratio 2.40
    Return on Assets (%) 2.32
    Return on Capital (%) 2.49
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 4.45
    Total Assets 2418.62
    Total Liabilities 2418.62
    Total Equity 2142.71
    Share Outstanding 8
    Price to Book Ratio 1.87
    Return on Assets (%) 1.11
    Return on Capital (%) 1.18
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 4.82
    Total Assets 2518.65
    Total Liabilities 2518.65
    Total Equity 2117.58
    Share Outstanding 8
    Price to Book Ratio 0.94
    Return on Assets (%) 2.27
    Return on Capital (%) 2.38
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 15.83
    Total Assets 2896.11
    Total Liabilities 2896.11
    Total Equity 2065.66
    Share Outstanding 8
    Price to Book Ratio 1.67
    Return on Assets (%) 4.86
    Return on Capital (%) 6.24
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 115.27
    Total Assets 2517.39
    Total Liabilities 2517.39
    Total Equity 1637.83
    Share Outstanding 8
    Price to Book Ratio 1.66
    Return on Assets (%) 7.32
    Return on Capital (%) 8.05
    Particulars MAR 2025 (Values in Cr)
    Net Income 122.33
    Cash from Operations 179.20
    Cash from Investing -199.08
    Cash from Financing 62.65
    Net change in Cash -4.25
    Free Cash Flow 422.83
    Particulars MAR 2024 (Values in Cr)
    Net Income 54.34
    Cash from Operations 177.85
    Cash from Investing -166.58
    Cash from Financing 46.77
    Net change in Cash 16.85
    Free Cash Flow 362.41
    Particulars MAR 2023 (Values in Cr)
    Net Income -38.27
    Cash from Operations 212.29
    Cash from Investing -232.61
    Cash from Financing 45.79
    Net change in Cash -6.89
    Free Cash Flow 438.96
    Particulars MAR 2022 (Values in Cr)
    Net Income 102.26
    Cash from Operations 139.61
    Cash from Investing -285.49
    Cash from Financing 82.85
    Net change in Cash -97.50
    Free Cash Flow 471.44
    Particulars MAR 2021 (Values in Cr)
    Net Income 195.05
    Cash from Operations 94.52
    Cash from Investing -404.27
    Cash from Financing 436.37
    Net change in Cash 79.02
    Free Cash Flow 448.77
    Particulars MAR 2025 (Values in Cr)
    Net Income 107.23
    Cash from Operations -1.69
    Cash from Investing -433.28
    Cash from Financing 450.08
    Net change in Cash -2.26
    Free Cash Flow 55.75
    Particulars MAR 2024 (Values in Cr)
    Net Income 38.08
    Cash from Operations 16.50
    Cash from Investing 155.82
    Cash from Financing -163.07
    Net change in Cash 2.30
    Free Cash Flow 71.57
    Particulars MAR 2023 (Values in Cr)
    Net Income 12.67
    Cash from Operations 10.49
    Cash from Investing -94.83
    Cash from Financing 87.67
    Net change in Cash -5.07
    Free Cash Flow 68.76
    Particulars MAR 2022 (Values in Cr)
    Net Income 192.89
    Cash from Operations 208.36
    Cash from Investing -378.97
    Cash from Financing 97.22
    Net change in Cash -107.87
    Free Cash Flow 381.81
    Particulars MAR 2021 (Values in Cr)
    Net Income 255.53
    Cash from Operations 112.97
    Cash from Investing -238.13
    Cash from Financing 255.57
    Net change in Cash 87.07
    Free Cash Flow 378.68
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.10 17.88 2.08 330.29 23.12 45.50
    BLISS GVS PHARMA LTD. 505.05 40.66 4.49 5365.85 118.35 552.90
    CIPLA LTD 1450.00 32.73 3.40 117137.57 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 551.65 25.80 3.99 1623.56 256.40 564.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.10 30.14 5.55 330.29 23.12 45.50
    AMRUTAJAN HEALTH LTD 525.20 23.54 4.10 1518.39 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8091.60 105.74 23.17 20229.00 7630.00 9850.00
    BLISS GVS PHARMA LTD. 505.05 54.66 4.64 5365.85 118.35 552.90

    SHILPA MEDICARE LTD shareholding pattern

    Holding
    40.42%
    40.13%
    11.38%
    8.05%
    8.73%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    SHILPA MEDICARE LTD Technicals Summary

    738.80 2.36 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 656.20
    • 26 Days 614.60
    • 10 Days 637.90
    • 50 Days 579.10
    • 12 Days 634.10
    • 100 Days 518.30
    • 20 Days 622.80
    • 200 Days 460.30
    704.15 PIVOT
    First Support 654.45 First Resistance 771.45 Second Support 587.15 Second Resistance 821.15 Third Support 537.45 Third Resistance 888.45
    RSI 75.17 ADX 39.47 MACD 19.50 Williams % R -20.53 Commodity Channel Index (CCI) 390.91
    Date 2026-08-05 Week 598969.00 Same Day 2155105.00 Month 351462.00
    1 Year 0.89 3 Year 1.04
    Over 1 Month
    20.95% down
    Over 1 Year
    67.47% down
    Over 3 Months
    70.06% down
    Over 3 Years
    59.04% down
    Over 6 Months
    128.47% down
    Over 5 Years
    18.54% down

    SHILPA MEDICARE LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    17 Sep 2025 1.0 Final 17 Sep 2025 Equity shares
    19 Sep 2022 1.1 Final 20 Sep 2022 Equity shares
    20 Sep 2021 1.1 Final 22 Sep 2021 Equity shares
    16 Mar 2020 1.1 Interim 17 Mar 2020 Equity shares
    12 Sep 2019 1.0 Final 14 Sep 2019 Equity shares
    01 Mar 2018 0.7 Interim 05 Mar 2018 Equity shares
    21 Mar 2017 0.6 Interim 22 Mar 2017 Equity shares
    28 Mar 2016 0.6 Interim 29 Mar 2016 Equity shares
    16 Sep 2015 1.1 Final 21 Sep 2015 Equity shares
    11 Sep 2014 1.0 Final 13 Sep 2014 Equity shares
    16 Jul 2013 1.3 Final 18 Jul 2013 Equity shares
    17 Sep 2012 0.9 Final 19 Sep 2012 Equity shares
    15 Sep 2011 0.8 Final 19 Sep 2011 Equity shares
    16 Sep 2010 0.7 Final 20 Sep 2010 Equity shares
    24 Sep 2009 0.5 Final 26 Sep 2009 Equity shares
    11 Sep 2008 0.4 Final 15 Sep 2008 Equity shares
    24 May 2007 2.0 Interim 26 May 2007 Equity shares
    26 Sep 2005 0.0 Final 27 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    03 Oct 2025 03 Oct 2025 1:1
    18 Jul 2013 16 Jul 2013 1:2
    Ex-Date Old FV NEW FV Record Date
    06 Nov 2015 2.0 1.0 09 Nov 2015
    28 Sep 2007 10.0 2.0 08 Oct 2007
    Dividend date Dividend amount Dividend type Record date Instrument type
    17 Sep 2025 1.0 Final 17 Sep 2025 Equity shares
    19 Sep 2022 1.1 Final 20 Sep 2022 Equity shares
    20 Sep 2021 1.1 Final 22 Sep 2021 Equity shares
    16 Mar 2020 1.1 Interim 17 Mar 2020 Equity shares
    12 Sep 2019 1.0 Final 14 Sep 2019 Equity shares
    01 Mar 2018 0.7 Interim 05 Mar 2018 Equity shares
    21 Mar 2017 0.6 Interim 22 Mar 2017 Equity shares
    28 Mar 2016 0.6 Interim 29 Mar 2016 Equity shares
    16 Sep 2015 1.1 Final 21 Sep 2015 Equity shares
    11 Sep 2014 1.0 Final 13 Sep 2014 Equity shares
    16 Jul 2013 1.3 Final 18 Jul 2013 Equity shares
    17 Sep 2012 0.9 Final 19 Sep 2012 Equity shares
    15 Sep 2011 0.8 Final 19 Sep 2011 Equity shares
    16 Sep 2010 0.7 Final 20 Sep 2010 Equity shares
    24 Sep 2009 0.5 Final 26 Sep 2009 Equity shares
    11 Sep 2008 0.4 Final 15 Sep 2008 Equity shares
    24 May 2007 2.0 Interim 26 May 2007 Equity shares
    26 Sep 2005 0.0 Final 27 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    03 Oct 2025 03 Oct 2025 1:1
    18 Jul 2013 16 Jul 2013 1:2
    Ex-Date Old FV NEW FV Record Date
    06 Nov 2015 2.0 1.0 09 Nov 2015
    28 Sep 2007 10.0 2.0 08 Oct 2007

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Shilpa Medicare Ltd?

    Answer Field

    Shilpa Medicare Ltd share price is for NSE ₹ 737.65 & for BSE ₹ 735.55 as on Aug 06 2026 03:30 PM.

    What is the Market Cap of Shilpa Medicare Ltd Share?

    Answer Field

    The market cap of Shilpa Medicare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 06 2026 03:30 PM.

    What is the 52 Week High and Low of Shilpa Medicare Ltd?

    Answer Field

    The 52 Week High and Low of Shilpa Medicare Ltd for NSE is ₹ 786.15 and ₹ 259.50 and for BSE is ₹ 786.55 and ₹ 260.00.

    What is 1 year return for Shilpa Medicare Ltd?

    Answer Field

    The 1 year returns on the stock has been 67.47%.

    What is the P/E Ratio of Shilpa Medicare Ltd Share?

    Answer Field

    As on Aug 06 2026 03:30 PM the price-to-earnings (PE) ratio for Shilpa Medicare Ltd share is 106.08.

    What is the PB ratio of Shilpa Medicare Ltd Share?

    Answer Field

    As on Aug 06 2026 03:30 PM, the price-to-book (PB) ratio for Shilpa Medicare Ltd share is 138.73.

    How to Buy Shilpa Medicare Ltd Share?

    Answer Field

    You can trade in Shilpa Medicare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Shilpa Medicare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Shilpa Medicare Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Shilpa Medicare Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |